Tides Medical
- Company typePrivate
- Founded2010
- HeadquartersLafayette, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Tides Medical firmographics
Firmographics- Name
- Tides Medical
- Legal name
- Tides Medical
- Website
- https://tidesmedical.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Tides Medical industry classification
Industry- Product category
- Regenerative Medicine
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
- akta.pro secondary industries
- 3D Bioprinting & Biofabrication (HLAAAGAC), Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware) (IMAAAAAG), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
Keywords
Where Tides Medical is headquartered
LocationHeadquarters
- HQ city
- Lafayette
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Tides Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Biologic Skin Substitute Sales: Sale of amniotic tissue graft products (Artacent AC, Artacent Wound, Artacent Flex, Artacent Ocular, Artacent Connect, Artacent Vericlen, AmnioHeal Plus, MLG Complete) and APLICOR 3D personalized grafts to healthcare providers for chronic wound treatment and surgical procedures.
- APLICOR 3D System: Single-use 3D bioprinting system components including scaffold kits (three sizes available to print 1cm² – 128 cm² graft), printer systems, and associated consumables for personalized wound care treatment.
- Contract Manufacturing Services: CDMO services including private labeling, kitting, aseptic processing, packaging, validation, distribution, inventory storage, and raw goods sourcing for biotech companies, medical device agencies, and startups in regenerative medicine and biologics sectors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Healthcare Provider Products |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Tides Medical product offering
Product offeringCore offering
Tides Medical processes donated human birth tissue (placentas) into amniotic tissue grafts used for wound care, surgical, and ophthalmology applications. The company operates a proprietary 3D bioprinting platform (APLICOR 3D) for tissue engineering and offers contract development and manufacturing organization (CDMO) services to other biotech firms.
Product overview
Tides Medical offers a comprehensive portfolio of amniotic tissue products and a 3D bioprinting platform for wound care and surgical applications. The core product line includes multiple Artacent brand grafts (AC, Connect, Flex, Ocular, Vericlen, Wound) differentiated by thickness (dual-layer, tri-layer, full-thickness) and application specialty (general wound care, ocular, surgical). Supporting products include AmnioHeal Plus for surgical settings and MLG Complete as a full-thickness allograft. The proprietary Artacleanse Process underlies all Artacent products, ensuring safety while maintaining natural biologic factors. APLICOR 3D represents an advanced 3D bioprinting platform that creates personalized grafts from the patient's own adipose tissue. Tides also distributes Aurix, a platelet rich plasma (PRP) system. All products are processed in-house at the company's AATB-accredited tissue bank in Lafayette, Louisiana, with distribution through a nationwide network of sales professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Artacent: Product line including Artacent AC (tri-layer amniotic tissue graft), Artacent Connect, Artacent Flex, Artacent Ocular, Artacent Vericlen, and Artacent Wound - amniotic tissue products for chronic wounds and surgical applications.
- APLICOR 3D
- LOFT
- Artacleanse
- Aurix
Products and services
- Artacent Family of Products A family of amniotic tissue grafts used in wound care, surgical, and ophthalmology applications, processed from donated placentas using proprietary Artacleanse and Arta-Pure technologies.
- Artacent AC An amniotic tissue graft product within the Artacent line, designed for wound care and surgical applications.
- Artacent Cord A cord-based amniotic tissue graft within the Artacent product family, used for wound healing applications.
- Artacent Wound An amniotic tissue graft specifically designed for wound care applications.
- Artacent Ocular An amniotic tissue graft designed specifically for ophthalmology applications.
- APLICOR 3D A 3D bioprinting platform developed for tissue engineering and regenerative medicine applications, used internally for R&D and offered to biotech partners.
- Aurix A regenerative medicine product used in wound healing and tissue repair applications.
- MLG Complete
Quantifiable outcome
- 226% revenue growth over three years (2022-2025)
- +4 more outcomes
Companies that use Tides Medical
Customer profileNamed customers13 records
Segments6 records
Ideal customer profiles2 records
Tides Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Tides Medical partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and supporting.
- Alliant PurchasingcoreTides Medical signed a membership agreement with Alliant Purchasing, a leading national group purchasing organization (GPO), to expand access to APLICOR 3D, the company's breakthrough 3D bioprinting platform for advanced wound care. This partnership leverages Alliant's network to increase market reach for personalized wound care solutions.
- VizientcoreTides Medical received an Innovative Technology Contract from Vizient for APLICOR 3D. Vizient is one of the largest healthcare performance improvement companies in the nation, serving more than 60% of healthcare organizations. This contract validates the innovative nature of the APLICOR 3D wound regeneration system.
- Nuo Therapeutics (Aurix)supportingAurix biodynamic hematogel system is distributed by Tides Medical but manufactured by Nuo Therapeutics. The product uses platelet-rich plasma from patients' own blood for wound management with a 96.5% positive response rate.
- Samaritan BiologicssupportingMLG Complete uses the proprietary Retain processing method from Samaritan Biologics. This process eliminates harsh mechanical and chemical washes prior to sterilization to ensure maximum preservation of naturally occurring collagen and glycosaminoglycan content.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Tides Medical competitors and assessment
Company assessmentEmerging players
- Celularity: Celularity develops placental-derived cellular therapies and allografts (e.g., Biovance, Interfyl) for wound care and regenerative medicine — an emerging competitor with a similar birth-tissue sourcing model but a cellular-therapy positioning adjacent to Tides' tissue-graft franchise.
- Organovo: Organovo is a bioprinting company developing 3D-printed human tissue for therapeutic and research applications — an emerging peer relevant to Tides' APLICOR 3D bioprinting platform, though currently at an earlier stage of commercial deployment.
Direct peers
- MiMedx: MiMedx is the largest U.S. pure-play in placental/amniotic tissue allografts (EpiFix, AmnioFix, AmnioCord) for wound care and surgical applications — the closest direct competitor to Tides' Artacent franchise in the same physician channels and Q-code reimbursement landscape.
- MTF Biologics: MTF Biologics is a non-profit tissue bank that recovers and processes birth tissues and musculoskeletal allografts, distributing amniotic membrane grafts through commercial partners. Directly comparable to Tides' LOFT/Artacent processing model and CDMO-style service offering.
- Organogenesis: Organogenesis is a leading regenerative medicine company selling skin substitutes and wound-care biologics (Apligraf, Dermagraft, PuraPly) to the same podiatry, wound-care, and surgical specialties Tides targets with Artacent products.
- AlloSource: AlloSource is an AATB-accredited tissue bank producing allografts for wound care, sports medicine, and orthopedic applications — directly comparable to Tides' tissue-bank operations and birth-tissue product portfolio.
Broad incumbents
- ConvaTec: ConvaTec is a global wound-care and ostomy company selling skin barriers, advanced dressings, and biologics into the same hospital, IDN, and home-care channels targeted by Tides' field sales force.
- Integra LifeSciences: Integra LifeSciences is a diversified medical-device company with a meaningful regenerative-technology and wound-care portfolio (Integra Dermal Regeneration Template, amniotic offerings). A broad incumbent overlapping with Tides in wound care and surgical specialties.
- Smith+Nephew: Smith+Nephew's Advanced Wound Management division competes across the same wound-care channels where Tides sells Artacent Wound and APLICOR 3D, with a much larger global sales footprint and broader product portfolio.
- Coloplast: Coloplast's Wound Care division competes in advanced wound care globally; while broader than Tides, it shares the same podiatry, wound-care clinic, and surgical customer base where Artacent Wound and AmnioHeal Plus are sold.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Tides Medical social profiles
Digital presenceTides Medical compliance and trust
Trust signalCompliance9 records
Tides Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tides Medical leadership team
Management profileNumber of profiles
Profiles10 records
Tides Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tides Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tides Medical
What does Tides Medical do?
Tides Medical processes donated human birth tissue (placentas) into amniotic tissue grafts used for wound care, surgical, and ophthalmology applications. The company operates a proprietary 3D bioprinting platform (APLICOR 3D) for tissue engineering and offers contract development and manufacturing organization (CDMO) services to other biotech firms.
Is Tides Medical a public or private company?
Tides Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tides Medical founded?
Tides Medical was founded in 2010. It employs 101 to 250 people.
Where is Tides Medical based?
Tides Medical is headquartered in Lafayette, United States, in the North America region.
How does Tides Medical make money?
Three revenue lines are on record. Biologic Skin Substitute Sales are the primary driver. The others are APLICOR 3D System and contract Manufacturing Services.
Who are Tides Medical's main competitors?
Emerging players on record are Celularity and Organovo. Direct peers are MiMedx, MTF Biologics, Organogenesis and AlloSource. Broad incumbents are ConvaTec, Integra LifeSciences, Smith+Nephew and Coloplast.
Does Tides Medical have an API?
No public API is recorded for Tides Medical.
What industry is Tides Medical in?
Tides Medical's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAC, 3D Bioprinting & Biofabrication. Its NAICS code is 3391 and its SIC code is 3842.